-
Asare G A, Mossanda K S, Kew M C. Hepatocellular carcinoma caused by iron overload: a possible mechanism of direct hepatocarcinogenicity[J]. Toxicology, 2006, 219(): 41-52. doi: 10.1016/j.tox.2005.11.006
-
Bertoletti A, Gehring A J. The immune response during hepatitis B virus infection[J]. J Gen Virol, 2006, 87(): 1439-1449. doi: 10.1099/vir.0.81920-0
-
Chen C N, Hsieh F J, Cheng Y M. Expression of inducible nitric oxide synthase and cycloo-xygenase-2 in angiogenesis and clinical outcome of human gastric cancer[J]. J Surg Oncol, 2006, 94(): 226-233. doi: 10.1002/(ISSN)1096-9098
-
Cullis E R, Kalber T L, Ashton S E. Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126[J]. Mi-crovasc Res, 2006, 71(): 76-84.
-
Dionne R. COX-2 inhibitors-IBC conference[J]. 12-13 April 1999, Coronado, CA, USA. Idrugs, 1999, 2(): 664-666.
-
Dooley A, Low S Y, Holmes A. Nitric oxide synthase expression and activity in the tight-skin mouse model of fibrosis[J]. Rheumatology (Oxford), 2008, 47(): 272-280.
-
Fabregat I, Roncero C, Fernández M. Survival and apoptosis: a dysregulated balance in liver cancer[J]. Liver Int, 2007, 27(): 155-162. doi: 10.1111/liv.2007.27.issue-2
-
He Y, Yang F, Wang F. The upregulation of expressed proteins in HepG2 cells transfected by the recombinant plasmid-containing HBx gene[J]. Scand J Immunol, 2007, 65(): 249-256. doi: 10.1111/sji.2007.65.issue-3
-
Huang J, Wu K, Zhang J. Putative tumor suppressor YueF affects the functions of hepatitis B virus X protein in hepatoma cell apoptosis and p53 expression[J]. Biotechnol Lett, 2008, 30(): 235-242. doi: 10.1007/s10529-007-9531-2
-
Kim Y C, Song K S, Yoon G. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis[J]. Oncogene, 2001, 20(): 16-23. doi: 10.1038/sj.onc.1203840
-
Lara-Pezzi E, Gómez-Gaviro M V, Gálvez B G. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metal-loproteinase-1 and cyclooxygenase-2 expression[J]. J Clin Invest, 2002, 110(): 1831-1838. doi: 10.1172/JCI200215887
-
Liu M, Yang Y, Gu C. Spike protein of SARS-CoV stimulates cyclooxygenase-2 expression via both calcium-dependent and calcium-independent protein kinase C pathways[J]. FASEB J, 2007, 21(): 1586-1596. doi: 10.1096/fj.06-6589com
-
McClain SL, Clippinger A J, Lizzano R. Hepatitis B virus replication is associated with an HBx-dependent mitochondrion-regulated increase in cytosolic calcium levels[J]. J Virol, 2007, 81(): 12061-12065. doi: 10.1128/JVI.00740-07
-
McGinty A, Chang Y W, Sorokin A. Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells[J]. J Biol Chem, 2000, 275(): 12095-12101. doi: 10.1074/jbc.275.16.12095
-
Miyamoto T, Saika S, Ueyama T. Cyclooxy-genase 2 expression in rat corneas after ethanol exposure[J]. J Cataract Refract Surg, 2006, 32(): 1736-1740. doi: 10.1016/j.jcrs.2006.05.005
-
Oishi N, Shilagardi K, Nakamoto Y. Hepatitis B virus X protein overcomes oncogenic RAS-induced senescence in human immortalized cells[J]. Cancer Sci, 2007, 98(): 1540-1548. doi: 10.1111/cas.2007.98.issue-10
-
Peng G, Zhang F, Zhang Q. Borna disease virus P protein inhibits nitric oxide synthase gene expression in astrocytes[J]. Virology, 2007, 366(): 446-452. doi: 10.1016/j.virol.2007.04.031
-
Pesce C, Grattarola M, Menini S. Cyclooxygenase 2 expression in vessels and nerves in reversal reaction leprosy[J]. Am J Trop Med Hyg, 2006, 74(): 1076-1077.
-
Seeger C, Mason W S. Hepatitis B virus biology[J]. Microbiol Mol Biol Rev, 2000, 64(): 51-68. doi: 10.1128/MMBR.64.1.51-68.2000
-
Tsujii M, Kawano S, Tsuji S. Cycloo-xygenase regulates angiogenesis induced by colon cancer cells[J]. Cell, 1998, 93(): 705-716. doi: 10.1016/S0092-8674(00)81433-6
-
Wei W, Huang W, Pan Y. Functional switch of viral protein HBx on cell apoptosis, transformation, and tumorigenesis in association with oncoprotein Ras[J]. Cancer Lett, 2006, 244(): 119-128. doi: 10.1016/j.canlet.2005.12.008
-
Williams C S, Tsujii M, Reese J. Host cyclooxygenase-2 modulates carcinoma growth[J]. J Clin Investig, 2000, 105(): 1589-1594. doi: 10.1172/JCI9621
-
Wullaert A, van Loo G, Heyninck K. Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: effects on liver homeostasis and beyond[J]. Endocr Rev, 2007, 28(): 365-386. doi: 10.1210/er.2006-0031
-
Yan X, Hao Q, Mu Y. Nucleocapsid protein of SARS-CoV activates the expression of cycloo-xygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein[J]. Int J Biochem Cell Biol, 2006, 38(): 1417-1428. doi: 10.1016/j.biocel.2006.02.003
-
Yang Q, Ito S, Gonzalez F J. Hepatocyte-restricted constitutive activation of PPAR alpha induces hepatoproli-feration but not hepatocarcinogenesis[J]. Carcinogenesis, 2007, 28(): 1171-1177. doi: 10.1093/carcin/bgm046
-
Yun C, Cho H, Kim S J. Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-activated protein/extracellular signal-regulated kinase-mitogen-activated protein pathway[J]. Mol Cancer Res, 2004, 2(): 159-2169.
-
Zhang J L, Zhao W G, Wu K L. Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin[J]. Arch Virol, 2005, 150(): 721-741. doi: 10.1007/s00705-004-0446-0